按现行指南逐步回撤REBOA球囊在失血性休克大动物模型中仍出现血流陡增与快速再灌注
研究在8头约克夏杂交猪中建立失血性休克模型,放血25%总血容量后休克30分钟,行60分钟Zone 1 REBOA,随后在回输失血复苏期间以每30秒0.5 mL速率逐步回撤球囊直至完全放气。结果:主动脉血流初始恢复时间中位数78秒(IQR 68-105秒),所有动物均在单次回撤步骤中出现主动脉血流快速增加(中位数819 mL/min,IQR 664-1241 mL/min),并伴近端MAP立即下降(中位数30 mm Hg,IQR 14.5-37 mm Hg)。球囊总容积与血流恢复时间无相关性(r=0.016),远端主动脉血流出现时间在动物间不一致,且与初始球囊容积或相对回撤容积无关。作者认为这首次刻画了REBOA球囊回撤过程中的主动脉血流动力学,仍需未来研究明确影响回撤期血流的因素以实现可控再灌注。
要点
- 在失血性休克猪模型中,按现行指南每30秒0.5 mL逐步回撤REBOA球囊,所有动物均出现单次回撤步骤中主动脉血流陡增(中位数819 mL/min,IQR 664-1241 mL/min)。
- 该血流陡增同时伴近端MAP立即下降,中位数30 mm Hg(IQR 14.5-37 mm Hg),提示回撤期仍可出现血流动力学不稳定。
- 主动脉血流初始恢复时间在动物间不一致,中位数78秒(IQR 68-105秒),且与球囊总容积无相关性(r=0.016)。
- 远端主动脉血流出现时间与初始球囊容积或相对回撤容积均无关,提示难以用容积参数预测再灌注起始。
- 作者认为需未来研究明确影响球囊回撤期主动脉血流的因素,以促进REBOA后可控再灌注。
适用人群与场景
- 8头约克夏杂交猪,行脾切除并置管后,经快速放血25%总血容量建立失血性休克模型。
- 休克30分钟后接受60分钟Zone 1 REBOA(使用低 profile REBOA 导管),随后在回输失血复苏期间逐步回撤球囊。
处置流程与药物剂量
- 在回输失血复苏期间,以每30秒0.5 mL的速率逐步回撤主动脉阻断球囊,直至完全放气。
- 回撤期间连续测量主动脉血流速率与近端平均动脉压(MAP)。
研究设计与关键结果
- 研究类型:大动物(猪)实验研究;样本量:8头约克夏杂交猪;人群:失血性休克模型。
- 干预:休克30分钟后行60分钟Zone 1 REBOA,随后在回输失血复苏期间以每30秒0.5 mL速率逐步回撤球囊直至完全放气;对照:无独立对照组,为自身前后观察。
- 主要终点结果:逐步回撤球囊后主动脉血流初始恢复时间中位数78秒(IQR 68-105秒);所有动物均出现单次回撤步骤中主动脉血流快速增加,中位数819 mL/min(IQR 664-1241 mL/min),并伴近端MAP立即下降,中位数30 mm Hg(IQR 14.5-37 mm Hg)。
- 关键次要终点:球囊总容积与血流恢复时间无相关性(r=0.016);远端主动脉血流出现时间在动物间不一致,且与初始球囊容积或相对回撤容积无关。
证据类型、等级与局限
- 证据类型:大动物(猪)实验研究(作者称首次刻画REBOA球囊回撤过程中的主动脉血流动力学)。
- 局限:作者指出需未来研究明确影响球囊回撤期主动脉血流的因素,以促进REBOA后可控再灌注。
对床旁实践的改变
- 作者认为,按现行指南以5分钟逐步回撤REBOA球囊的方法,在本失血性休克猪模型中仍出现不可预测的主动脉血流速率和血流动力学不稳定。
- 作者认为,球囊回撤过程中存在陡峭拐点,导致主动脉血流骤增并伴MAP下降,且远端血流出现时间与球囊容积参数无关。
- 作者建议未来研究明确影响球囊回撤期主动脉血流的因素,以促进REBOA后可控再灌注。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: To avoid potential cardiovascular collapse after resuscitative endovascular balloon occlusion of the aorta (REBOA), current guidelines recommend methodically deflating the balloon for 5 minutes to gradually reperfuse distal tissue beds. However, anecdotal evidence suggests that this approach may still result in unpredictable aortic flow rates and hemodynamic instability. We sought to characterize aortic flow dynamics following REBOA as the balloon is deflated in accordance with current practice guidelines.
METHODS: Eight Yorkshire-cross swine were splenectomized, instrumented, and subjected to rapid 25% total blood volume hemorrhage. After 30 minutes of shock, animals received 60 minutes of Zone 1 REBOA with a low-profile REBOA catheter. During subsequent resuscitation with shed blood, the aortic occlusion balloon was gradually deflated in stepwise fashion at the rate of 0.5 mL every 30 seconds until completely deflated. Aortic flow rate and proximal mean arterial pressure (MAP) were measured continuously over the period of balloon deflation.
RESULTS: Graded balloon deflation resulted in variable initial return of aortic flow (median, 78 seconds; interquartile range [IQR], 68-105 seconds). A rapid increase in aortic flow during a single-balloon deflation step was observed in all animals (median, 819 mL/min; IQR, 664-1241 mL/min) and corresponded with an immediate decrease in proximal MAP (median, 30 mm Hg; IQR, 14.5-37 mm Hg). Total balloon volume and time to return of flow demonstrated no correlation (r = 0.016).
CONCLUSION: This study is the first to characterize aortic flow during balloon deflation following REBOA. A steep inflection point occurs during balloon deflation that results in an abrupt increase in aortic flow and a concomitant decrease in MAP. Furthermore, the onset of distal aortic flow was inconsistent across study animals and did not correlate with initial balloon volume or relative deflation volume. Future studies to define the factors that affect aortic flow during balloon deflation are needed to facilitate controlled reperfusion following REBOA.
参考来源
- Davidson AJ, Russo RM, Ferencz SE, et al. Incremental balloon deflation following complete resuscitative endovascular balloon occlusion of the aorta results in steep inflection of flow and rapid reperfusion in a large animal model of hemorrhagic shock. J Trauma Acute Care Surg. 2017. PMID: 28632583. doi:10.1097/TA.0000000000001502
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。